A Phase I/II Study of JL19001 Injection Alone or in Combination With BCG in Subjects With High Risk Non-Muscle Invasive Bladder Cancer.
Clinical trial NCT07483970 · RECRUITING
Trial details
- NCT number
- NCT07483970
- Sponsor
- Jecho Biopharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-18
- Primary completion
- 2027-03-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.